Indefinite Delivery Contract SPE2DR25D1208

The federal contract IDV award SPE2DR25D1208 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has an ultimate completion date of December 31, 2036 and covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, and infectious disease prevention.

The contract stems from a pre-solicitation issued by DLA Troop Support for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The procurement is designated as an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation criteria. The government intends to make at least three regional awards, with Amerisourcebergen holding one of the primary supplier contracts.